|1.||De Clercq, Erik: 7 articles (02/2013 - 08/2005)|
|2.||Reiss, Peter: 6 articles (03/2013 - 02/2009)|
|3.||Fontas, Eric: 5 articles (03/2013 - 02/2009)|
|4.||Weber, Rainer: 5 articles (03/2013 - 02/2009)|
|5.||Lundgren, Jens D: 5 articles (03/2013 - 02/2009)|
|6.||Friis-Møller, Nina: 5 articles (01/2012 - 02/2009)|
|7.||El-Sadr, Wafaa: 5 articles (01/2012 - 02/2009)|
|8.||De Wit, Stephane: 5 articles (01/2012 - 02/2009)|
|9.||Tamamura, Hirokazu: 4 articles (10/2013 - 06/2004)|
|10.||Worm, Signe W: 4 articles (03/2013 - 02/2009)|
|1.||Acquired Immunodeficiency Syndrome (AIDS)
08/26/2008 - "These EM derivatives may be highly beneficial for repression of residual HIV-1 in the lymphoreticular system of HIV-1-infected patients and offer great promise for the creation of new anti-HIV drugs for the future treatment of AIDS patients."
07/01/2000 - "This study evaluates the effects of Florida's participation in the Medicaid acquired immunodeficiency syndrome (AIDS) home and community-based waiver and the use of recently developed AIDS drugs on spending per Medicaid beneficiary. "
03/01/1997 - "From this study several classes of low microM anti-HIV agents with simple chemical structures were identified as possible chemotherapeutic agents for the treatment of AIDS."
01/01/1995 - "The Inter-Company Collaboration for AIDS Drug Development (ICC) represents a collaborative effort among member companies to facilitate the conduct of clinical trials on AIDS drugs. "
07/01/2015 - "Transport of the anti-HIV agents across the blood-brain barrier (BBB) is a prerequisite to treat acquired immunodeficiency syndrome (AIDS) related encephalopathy. "
07/01/2006 - "Thus, ACA may represent a novel treatment for HIV-1 infection, especially in combination with other anti-HIV drugs."
10/01/2015 - "In this study, we evaluated the inhibitory activity of a wide variety of anti-HIV drugs, focusing on the impact that different infection pathways have on their efficacy. "
01/01/2001 - "Large study finds hepatitis C virus infection linked to reduced benefit from anti-HIV drugs."
01/01/2014 - "The interaction of the HIV-1 fusion protein gp120 with its cellular receptor CD4 represents a crucial step of the viral infection process, thus rendering gp120 a promising target for the intervention with anti-HIV drugs. "
01/01/2010 - "Drugs based on amino acid sequence of Heptad Repeats of gp41 of HIV have been explored in search of anti-HIV drugs acting by inhibition of the gp41 6-helix formation and subsequent cellular infection. "
|3.||HIV Infections (HIV Infection)
09/01/2015 - "In conclusion, these results reveal a novel link between LXR stimulation and cell resistance to HIV infection and suggest that LXR agonists may be good candidates for development as anti-HIV agents, in particular for pre-exposure prophylaxis of HIV infection. "
01/01/2015 - "We assessed CVD risk factors, the estimated 5-year Data collection on adverse effects of anti-HIV drugs (DA.) risk score and the 10-year Framingham risk score in persons with HIV infection on ART in a rural area in South Africa. "
01/01/2015 - "Patients could allow or restrict providers' access to all data (diagnoses, medications, test results, reports, etc.) or only highly sensitive data (sexually transmitted infections, HIV/AIDS, drugs/alcohol, mental or reproductive health). "
10/01/2014 - "The current therapy for the human immunodeficiency virus (HIV) infection is a combination of anti-HIV drugs targeting multiple steps of virus replication. "
02/01/2013 - "This review will summarize the recently emerging knowledge on these novel factors and their potential relevance for the discovery of new anti-HIV agents targeting not only the replicative, but also the latent state of HIV infection."
|4.||Retroviridae Infections (Infection, Retrovirus)
|5.||Nephrotic Syndrome (Syndrome, Nephrotic)
10/01/2011 - "Although anti-viral treatment for patients with HBV-associated MN has been suggested to be clinically effective, the use of two anti-HIV agents (tenofovir and emtricitabine), both of which have anti-HBV activities, was not effective for the patient's nephrotic syndrome, despite obtaining a decrease in the serum HBV-DNA levels. "
|3.||RNA (Ribonucleic Acid)
|6.||DNA (Deoxyribonucleic Acid)
|1.||Highly Active Antiretroviral Therapy (HAART)
|3.||Drug Therapy (Chemotherapy)